Clinical Trial Failure:
Billions Wasted.
Countless Opportunities Lost for Patients.
Our Deep Network Biology & Proven AI Ranking Models Accurately Predict Clinical Trial Failure.
This Changes Everything.
Clinical Trial Ranking Report
The Prediction Engine for Clinical Research
Our Proprietary Platform Is Enabling Accurate, Precise Predictive Analytics for Clinical Trials
Scipher Medicine has spent more than 10 years of research and development to build their foundational Spectra AI Platform. This novel analytics technology identifies the biological mechanisms in the protein to protein interactome that drive drug response. It provides an unprecedented view into human disease, network biology, and possible drug targets.
Clinical Trial Ranking Report is applying Scipher’s Spectra AI Platform, integrated with a broad range of custom analytics, to enable confident, data-driven, go/no-go decisions on clinical research for the BioPharma industry.
The Clinical Research Ecosystem is Broken
of Phase III trials fail, costing up to $1.3 billion per drug.
of clinical trials fail to meet enrollment timelines.
improvement in success rates could save more than $30 billion/yr.
The Cost of Clinical Trial Failure is Staggering.
Every year, over $40 billion is spent on clinical trials that ultimately fail to reach their endpoints. For BioPharma, investors, and researchers, these failures waste resources, burn time, and miss opportunities to deliver life-changing therapies to patients.
The Clinical Trial Ranking Report is transforming the clinical research landscape.
Our advanced AI platform predicts trial failure with unmatched accuracy—helping you make smarter investment decisions, optimize resource allocation, and accelerate breakthrough discoveries.